🚧 Under construction — Data may be inaccurate. We are actively adding more companies and metrics.

Regeneron Pharmaceuticals, Inc. vs Intercontinental Exchange, Inc.

Market cap comparison over time

Regeneron Pharmaceuticals, Inc.

$96.8B

Rank #167

Intercontinental Exchange, Inc.

$99.6B

Rank #163

Market Cap Over Time

Key Moments

  • Regeneron Pharmaceuticals, Inc. overtook Intercontinental Exchange, Inc. by 2012
  • Intercontinental Exchange, Inc. overtook Regeneron Pharmaceuticals, Inc. by 2018
  • Regeneron Pharmaceuticals, Inc. overtook Intercontinental Exchange, Inc. by 2022
  • Intercontinental Exchange, Inc. overtook Regeneron Pharmaceuticals, Inc. by 2024

Year-by-Year Comparison

YearRegeneron Pharmaceuticals, Inc.Intercontinental Exchange, Inc.Leader
2026$96.8B$99.6BIntercontinental Exchange, Inc.
2025$79.3B$91.0BIntercontinental Exchange, Inc.
2024$72.8B$82.8BIntercontinental Exchange, Inc.
2023$89.7B$70.5BRegeneron Pharmaceuticals, Inc.
2022$73.7B$55.4BRegeneron Pharmaceuticals, Inc.
2021$64.5B$72.9BIntercontinental Exchange, Inc.
2020$49.4B$60.8BIntercontinental Exchange, Inc.
2019$38.4B$48.2BIntercontinental Exchange, Inc.
2018$38.2B$38.7BIntercontinental Exchange, Inc.
2017$38.4B$35.8BRegeneron Pharmaceuticals, Inc.
2016$37.5B$28.3BRegeneron Pharmaceuticals, Inc.
2015$55.5B$25.4BRegeneron Pharmaceuticals, Inc.
2014$41.9B$21.4BRegeneron Pharmaceuticals, Inc.
2013$28.1B$21.7BRegeneron Pharmaceuticals, Inc.
2012$17.5B$11.9BRegeneron Pharmaceuticals, Inc.
2011$5.7B$11.6BIntercontinental Exchange, Inc.
2010$3.4B$11.5BIntercontinental Exchange, Inc.
2009$2.5B$10.8BIntercontinental Exchange, Inc.
2008$1.9B$8.0BIntercontinental Exchange, Inc.
2007$2.5B$18.6BIntercontinental Exchange, Inc.
2006$2.1B$10.4BIntercontinental Exchange, Inc.
2005$1.6B$3.5BIntercontinental Exchange, Inc.